diabetes mellitus, type 2
Showing NaN - NaN of 79
Diabetes, Type 2, Non-Alcoholic Fatty Liver Disease Trial in Canada, United States (BFKB8488A, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Non-Alcoholic Fatty Liver Disease
- BFKB8488A
- Placebo
-
Anniston, Alabama
- +17 more
Mar 25, 2020
Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )
Completed
- Diabetes Mellitus, Type 2
- Ticagrelor 60 mg
- Ticagrelor placebo
-
Alexander City, Alabama
- +1241 more
Mar 4, 2020
Tresiba® After Switching Basal Insulin inPopulation With Type 1
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Insulin degludec
-
Calgary, Alberta, Canada
- +31 more
Dec 5, 2019
Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathy
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +592 more
Dec 4, 2019
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Insulin
-
Huntington Beach, California
- +59 more
Sep 6, 2019
Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)
Completed
- Diabetes Mellitus, Type 2
- Insulin glargine, 300 U/ml
- +3 more
-
Birmingham, Alabama
- +426 more
Aug 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +85 more
May 28, 2019
Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +2 more
-
Glendale, Arizona
- +143 more
Jan 10, 2019
Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,
Completed
- Diabetes Mellitus, Type 2
- +2 more
- Placebo
- +2 more
-
Birmingham, Alabama
- +312 more
Nov 5, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Phoenix, Arizona
- +105 more
Sep 3, 2018
Diabetes, Type 2 Trial in Canada (rosiglitazone/metformin)
Completed
- Diabetes Mellitus, Type 2
-
Calgary, Alberta, Canada
- +90 more
Mar 19, 2018
Diabetes, Type 2 Trial in Worldwide (rosiglitazone maleate/metformin HCl)
Completed
- Diabetes Mellitus, Type 2
- rosiglitazone maleate/metformin hydrochloride
-
Anniston, Alabama
- +101 more
Mar 19, 2018
Diabetes, Type 2 Trial in Worldwide (Insulin Pump (Medtronic Minimed Paradigm® VEO))
Completed
- Diabetes Mellitus, Type 2
- Insulin Pump (Medtronic Minimed Paradigm® VEO)
-
Atlanta, Georgia
- +35 more
Feb 6, 2018
Type 2 Diabetes Mellitus inUsual Clinical Practice in Canada
Completed
- Diabetes Mellitus, Type 2
- No Intervention
-
Calgary, Alberta, Canada
- +22 more
Oct 27, 2017
Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )
Terminated
- Diabetes Mellitus, Type 2
- pioglitazone
- +4 more
-
Long Beach, California
- +330 more
Mar 21, 2017
Diabetes, Type 2 Trial in Worldwide (Pioglitazone, GW677954)
Completed
- Diabetes Mellitus, Type 2
-
Birmingham, Alabama
- +142 more
Mar 21, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Birmingham, Alabama
- +165 more
Jan 25, 2017